Gliomas: Association of histology and molecular genetic analysis of chromosomes 1p, 10q, and 19q

Acta Neurobiologiae Experimentalis

Volumn 67, Issue 2, 2007, Pages 103-112

  Gresner, Sylwia M ^a   Rieske, Piotr ^a   Wozniak, Krystyna ^a   Piaskowski, Sylwester ^a   Jaskolski, Dariusz J ^a   Skowronski, Wiesław ^b   Sikorska, Beata ^a   Papierz, Wielislaw ^a   Liberski, Pawel P ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b Regional Hospital   (Poland)

Author keywords

10q; And 19q; Astrocytoma; Glioblastoma; Loss of heterozygosity (LOH) on chromosomes 1p; Oligoastrocytoma; Oligodendroglioma

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; ASTROCYTOMA; CHROMOSOME 10Q; CHROMOSOME 19P; CHROMOSOME 1P; CHROMOSOME DELETION; CHROMOSOME LOSS; CLINICAL ARTICLE; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FEMALE; GENE DELETION; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GLIOBLASTOMA; GLIOMA; HETEROZYGOSITY LOSS; HISTOLOGY; HUMAN; HUMAN TISSUE; MALE; MOLECULAR GENETICS; OLIGODENDROGLIOMA; PREVALENCE; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE;

ADULT; AGE FACTORS; AGED; CHROMOSOME ABERRATIONS; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 10; CHROMOSOMES, HUMAN, PAIR 19; FEMALE; GLIOMA; HUMANS; LOSS OF HETEROZYGOSITY; MALE; MIDDLE AGED; SEX FACTORS; STATISTICS;

EID: 34447511502     PISSN: 00651400     EISSN: 00651400     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Barbashina V, Salazar P, Holland EC, Rosenblum MK, Ladanyi M (2005) Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene. Clin Cancer Res 11: 1119-1128.
2. Batchelor TT, Betensky RA, Esposito JM, Pham LD, Dorfman MV, Piscatelli N, Jhung S, Rhee D, Louis DN (2004) Age-dependent prognostic effects of genetic alterations in glioblastoma. Clin Cancer Res 10: 228-233.
3. Bigner SH, Matthews MR, Rasheed BK, Wiltshire RD, Friedman HS, Friedman AH, Stenzel T, Dawes DM, McLendon RE, Bigner DD (1999) Molecular genetic aspects of oligodendrogliomas including analysis by comparative genomic hybridization. Am J Pathol 155: 375-386.
4. Cairncross JG, Ueki K, Zlatescu MC, Lisle DK, Finkelstein DM, Hammond RR, Silver JS, Stark PC, Macdonald DR, Ino Y, Ramsay DA, Louis DN (1998) Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Inst 90: 1473-1479.
5. Collins VP (2004) Brain tumours: classification and genes. J Neurol Neurosurg Psychiatry 75 (Suppl 2): ii2-ii11.
6. Eoli M, Silvani A, Pollo B, Bianchessi D, Menghi F, Valletta L, Broggi G, Boiardi A, Bruzzone MG, Finocchiaro G (2006) Molecular markers of gliomas: a clinical approach. Neurol Res 28: 538-541.
7. Fallon KB, Palmer CA, Roth KA, Nabors LB, Wang W, Carpenter M, Banerjee R, Forsyth P, Rich K, Perry A (2004) Prognostic value of 1p, 19q, 9p, 10q, and EGFR-FISH analyses in recurrent oligodendrogliomas. J Neuropathol Exp Neurol 63: 314-322.
8. Felsberg J, Erkwoh A, Sabel MC, Kirsch L, Fimmers R, Blaschke B, Schlegel U, Schramm J, Wiestler OD, Reifenberger G (2004) Oligodendroglial tumors: refinement of candidate regions on chromosome arm 1p and correlation of 1p/19q status with survival. Brain Pathol 14: 121-130.
9. Fujisawa H, Kurrer M, Reis RM, Yonekawa Y, Kleihues P, Oghaki H (1999) Acquisition of the glioblastoma phenotype during astrocytoma progression is associated with loss of heterozygosity on 10q25-qter. Am J Pathol 155: 387-394.
10. Fults D, Brockmayer D, Tullous MW, Pedone CA, Cawthon RM (1992) p53 mutation and loss of heterozygosity on chromosome 17 and during human astrocytoma progression. Cancer Res 52: 674-679.
11. Gresner SM, Rieske P, Wozniak K, Piaskowski S, Jaskolski DJ, Skowronski W, Sikorska B, Liberski PP (2006) Molecular analysis of chromosome 1, 10 and 19 abnormalities in human oligodendroglial tumors: relationship between frequency of LOH with grade, age and gender. Clin Neuropathol 25: 18-24.
12. Houillier C, Lejeune J, Benouaich-Amiel A, Laigle-Donadey F, Criniere E, Mokhtari K, Thillet J, Delattre JY, Hoang-Xuan K, Sanson M (2006) Prognostic impact of molecular markers in a series of 220 primary glioblastomas. Cancer 106: 2218-2223.
13. Kleihues P, Cavenee WK (2000) Pathology and Genetics of Tumors of Nervous System. IARC Press, Lyon, p. 56-67.
14. Kraus JA, Koopmann J, Kaskel P, Maintz D, Brandner S, Schramm J, Louis DN, Wiestler OD, von Deimling A (1995) Shared allelic losses on chromosomes 1p and 19q suggest a common origin of oligodendroglioma and oligoastrocytoma. J Neuropathol Exp Neurol 54: 91-95.
15. Lin H, Bondy ML, Langford LA, Hess KR, Delclos GL, Wu X, Chan W, Pershouse MA, Yung WK, Steck PA (1998) Allelic deletion analyses of MMAC/PTEN and DMBT1 loci in gliomas: relationship to prognostic significance. Clin Cancer Res 4: 2447-2454.
16. Louis DN, Gusella JF (1995) A tiger behind many doors: multiple genetic pathways to malignant glioma. Trends Genet 11: 412-415.
17. Maher EA, Furnari FB, Bachoo RM, Rowitch DH, Louis DN, Cavenee WK, DePinho RA (2001) Malignant glioma: genetics and biology of a grave matter. Genes Dev 15: 1311-1333.
18. Myal Y, Del Bigio MR, Rhodes RH (2003) Age-related differences in 1p and 19q deletions in oligodendrogliomas. BMC Clin Pathol 3: 6.
19. Ohgaki H, Kleihues P (2005) Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. J Neuropathol Exp Neurol 64: 479-489.
20. Ohgaki H, Dessen P, Jourde B, Horstmann S, Nishikawa T, Di Patre PL, Burkhard C, Schuler D, Probst-Hensch NM, Maiorka PC, Baeza N, Pisani P, Yonekawa Y, Yasargil MG, Lutolf UM, Kleihues P (2004) Genetic pathways to glioblastoma: a population-based study. Cancer Res 64: 6892-6899.
21. Okamoto Y, Di Patre PL, Burkhard C, Horstmann S, Jourde B, Fahey M, Schuler D, Probst-Hensch NM, Yasargil MG, Yonekawa Y, Lutolf UM, Kleihues P, Ohgaki H (2004) Population-based study on incidence, survival rates, and genetics alterations of low-grade astrocytomas and oligodendrogliomas. Acta Neuropathol 108: 49-56.
22. Rasheed BK, Wiltshire RN, Bigner SH, Bigner DD (1999) Molecular pathogenesis of malignant gliomas. Curr Opin Oncol 11: 162-167.
23. Reifenberger J, Reifenberger G, Liu L, James CD, Wechsler W, Collins VP (1994) Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19qand 1p. Am J Pathol 145: 1175-1190.
24. Ritland SR, Ganju V, Jenkins RB (1995) Region-specific loss of heterozygosity on chromosome 19 is related to the morphologic type of human glioma. Genes Chromosomes Cancer 12: 277-282.
25. Shibata DK, Arnheim N, Martin WJ. (1988) Detection of human papilloma virus in paraffin-embedded tissue using the polymerase chain reaction. J Exp Med. 167:225-230.
26. Smith JM, Jenkins RB (2000) Genetic alterations in adult diffuse glioma: occurrence, significant and prognostic implications. Front Biosci 5: D213-D231.
27. Tada K, Shiraishi S, Kamiryo T, Nakamura H, Hirano H, Kuratsu J, Kochi M, Saya H, Ushio Y (2001) Analysis of loss of heterozygosity on chromosome 10 in patients with malignant astrocytic tumors: correlation with patient age and survival. J Neurosurg 95: 651-659.
28. Thiessen B, Maguire JA, McNeil K, Huntsman D, Martin MA, Horsman D (2003) Loss of heterozygosity for loci on chromosome arms 1p and 10q in oligodendroglial tumors: relationship to outcome and chemosensitivity. J Neurooncol 64: 271-278.
29. Ueki K, Nishikawa R, Nakazato Y, Hirose T, Hirato J, Funada N, Fujimaki T, Hojo S, Kubo O, Ide T, Usui M, Ochiai C, Ito S, Takahashi H, Mukasa A, Asai A, Kirino T (2002) Correlation of histology and molecular genetic analysis of 1p, 19q, 10q, TP53, EGFR CDK4, and CDKN2A in 91 astrocytic and oligodendroglial tumors. Clin Cancer Res 8: 196-201.
30. Yoshimoto K, Iwaki T, Inamura T, Fukui M, Tahira T, Hayashi K (2002) Multiplexed analysis of post-PCR fluorescence-labeled microsatellite alleles and statistical evaluation of their balance in brain tumors. Jpn J Cancer Res 93: 284-290.